Logo image of ALL

ALLSTATE CORP (ALL) Stock Fundamental Analysis

NYSE:ALL - New York Stock Exchange, Inc. - US0200021014 - Common Stock - Currency: USD

193.9  +1.9 (+0.99%)

After market: 193.9 0 (0%)

Fundamental Rating

4

Taking everything into account, ALL scores 4 out of 10 in our fundamental rating. ALL was compared to 143 industry peers in the Insurance industry. ALL has a bad profitability rating. Also its financial health evaluation is rather negative. ALL is not valued too expensively and it also shows a decent growth rate. Finally ALL also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALL had positive earnings in the past year.
ALL had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALL reported negative net income in multiple years.
ALL had a positive operating cash flow in each of the past 5 years.
ALL Yearly Net Income VS EBIT VS OCF VS FCFALL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

1.2 Ratios

With a decent Return On Assets value of 3.41%, ALL is doing good in the industry, outperforming 73.43% of the companies in the same industry.
The Return On Equity of ALL (17.81%) is better than 81.12% of its industry peers.
Industry RankSector Rank
ROA 3.41%
ROE 17.81%
ROIC N/A
ROA(3y)0.78%
ROA(5y)1.63%
ROE(3y)3.78%
ROE(5y)7.06%
ROIC(3y)N/A
ROIC(5y)N/A
ALL Yearly ROA, ROE, ROICALL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

1.3 Margins

ALL has a Profit Margin (6.01%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ALL has declined.
ALL has a Operating Margin of 8.40%. This is comparable to the rest of the industry: ALL outperforms 44.06% of its industry peers.
In the last couple of years the Operating Margin of ALL has declined.
Industry RankSector Rank
OM 8.4%
PM (TTM) 6.01%
GM N/A
OM growth 3Y-11.15%
OM growth 5Y-7.38%
PM growth 3Y34.22%
PM growth 5Y-8.82%
GM growth 3YN/A
GM growth 5YN/A
ALL Yearly Profit, Operating, Gross MarginsALL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

3

2. Health

2.1 Basic Checks

ALL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALL has more shares outstanding
The number of shares outstanding for ALL has been reduced compared to 5 years ago.
ALL has a better debt/assets ratio than last year.
ALL Yearly Shares OutstandingALL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ALL Yearly Total Debt VS Total AssetsALL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

ALL has a debt to FCF ratio of 0.90. This is a very positive value and a sign of high solvency as it would only need 0.90 years to pay back of all of its debts.
ALL has a better Debt to FCF ratio (0.90) than 69.23% of its industry peers.
ALL has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.37, ALL perfoms like the industry average, outperforming 44.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 0.9
Altman-Z N/A
ROIC/WACCN/A
WACC8.37%
ALL Yearly LT Debt VS Equity VS FCFALL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ALL Yearly Current Assets VS Current LiabilitesALL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 127.79% over the past year.
ALL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.88% yearly.
Looking at the last year, ALL shows a quite strong growth in Revenue. The Revenue has grown by 11.49% in the last year.
The Revenue has been growing by 9.06% on average over the past years. This is quite good.
EPS 1Y (TTM)127.79%
EPS 3Y11.04%
EPS 5Y11.88%
EPS Q2Q%-31.19%
Revenue 1Y (TTM)11.49%
Revenue growth 3Y8.21%
Revenue growth 5Y9.06%
Sales Q2Q%8.45%

3.2 Future

The Earnings Per Share is expected to grow by 8.48% on average over the next years. This is quite good.
ALL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.95% yearly.
EPS Next Y0.1%
EPS Next 2Y9.33%
EPS Next 3Y8.48%
EPS Next 5YN/A
Revenue Next Year7.68%
Revenue Next 2Y7.95%
Revenue Next 3Y8.04%
Revenue Next 5Y6.95%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALL Yearly Revenue VS EstimatesALL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B
ALL Yearly EPS VS EstimatesALL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15 20

5

4. Valuation

4.1 Price/Earnings Ratio

ALL is valuated reasonably with a Price/Earnings ratio of 11.60.
ALL's Price/Earnings is on the same level as the industry average.
ALL is valuated cheaply when we compare the Price/Earnings ratio to 27.91, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 8.85, the valuation of ALL can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALL indicates a somewhat cheap valuation: ALL is cheaper than 63.64% of the companies listed in the same industry.
ALL is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.6
Fwd PE 8.85
ALL Price Earnings VS Forward Price EarningsALL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

ALL's Enterprise Value to EBITDA is on the same level as the industry average.
67.83% of the companies in the same industry are more expensive than ALL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.73
EV/EBITDA 9.62
ALL Per share dataALL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)115.03
PEG (5Y)0.98
EPS Next 2Y9.33%
EPS Next 3Y8.48%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.01%, ALL is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.30, ALL pays a better dividend. On top of this ALL pays more dividend than 90.21% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, ALL pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.01%

5.2 History

The dividend of ALL is nicely growing with an annual growth rate of 11.11%!
ALL has paid a dividend for at least 10 years, which is a reliable track record.
ALL has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.11%
Div Incr Years14
Div Non Decr Years15
ALL Yearly Dividends per shareALL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

27.76% of the earnings are spent on dividend by ALL. This is a low number and sustainable payout ratio.
ALL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27.76%
EPS Next 2Y9.33%
EPS Next 3Y8.48%
ALL Yearly Income VS Free CF VS DividendALL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B
ALL Dividend Payout.ALL Dividend Payout, showing the Payout Ratio.ALL Dividend Payout.PayoutRetained Earnings

ALLSTATE CORP

NYSE:ALL (7/29/2025, 8:04:00 PM)

After market: 193.9 0 (0%)

193.9

+1.9 (+0.99%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners81.03%
Inst Owner Change-1.53%
Ins Owners0.55%
Ins Owner Change4%
Market Cap51.35B
Analysts80.8
Price Target239.02 (23.27%)
Short Float %1.65%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield 6.01%
Yearly Dividend4.09
Dividend Growth(5Y)11.11%
DP27.76%
Div Incr Years14
Div Non Decr Years15
Ex-Date08-29 2025-08-29 (1)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.97%
Min EPS beat(2)20.62%
Max EPS beat(2)41.32%
EPS beat(4)4
Avg EPS beat(4)114.82%
Min EPS beat(4)20.62%
Max EPS beat(4)333.04%
EPS beat(8)7
Avg EPS beat(8)75.1%
EPS beat(12)10
Avg EPS beat(12)54.17%
EPS beat(16)11
Avg EPS beat(16)37.41%
Revenue beat(2)1
Avg Revenue beat(2)0.28%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)2.27%
Revenue beat(4)1
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-2.51%
Max Revenue beat(4)2.27%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)5
Avg Revenue beat(12)2.58%
Revenue beat(16)9
Avg Revenue beat(16)7.14%
PT rev (1m)0.49%
PT rev (3m)2.12%
EPS NQ rev (1m)4.58%
EPS NQ rev (3m)5.09%
EPS NY rev (1m)0.96%
EPS NY rev (3m)4.52%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.52%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE 11.6
Fwd PE 8.85
P/S 0.79
P/FCF 5.73
P/OCF 5.56
P/B 2.33
P/tB 2.71
EV/EBITDA 9.62
EPS(TTM)16.72
EY8.62%
EPS(NY)21.9
Fwd EY11.29%
FCF(TTM)33.86
FCFY17.46%
OCF(TTM)34.85
OCFY17.97%
SpS246.58
BVpS83.28
TBVpS71.52
PEG (NY)115.03
PEG (5Y)0.98
Profitability
Industry RankSector Rank
ROA 3.41%
ROE 17.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 8.4%
PM (TTM) 6.01%
GM N/A
FCFM 13.73%
ROA(3y)0.78%
ROA(5y)1.63%
ROE(3y)3.78%
ROE(5y)7.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-11.15%
OM growth 5Y-7.38%
PM growth 3Y34.22%
PM growth 5Y-8.82%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 0.9
Debt/EBITDA 1.34
Cap/Depr 47.03%
Cap/Sales 0.4%
Interest Coverage 250
Cash Conversion 152.77%
Profit Quality 228.37%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score9
WACC8.37%
ROIC/WACCN/A
Cap/Depr(3y)41.78%
Cap/Depr(5y)40.4%
Cap/Sales(3y)0.54%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)127.79%
EPS 3Y11.04%
EPS 5Y11.88%
EPS Q2Q%-31.19%
EPS Next Y0.1%
EPS Next 2Y9.33%
EPS Next 3Y8.48%
EPS Next 5YN/A
Revenue 1Y (TTM)11.49%
Revenue growth 3Y8.21%
Revenue growth 5Y9.06%
Sales Q2Q%8.45%
Revenue Next Year7.68%
Revenue Next 2Y7.95%
Revenue Next 3Y8.04%
Revenue Next 5Y6.95%
EBIT growth 1Y165.8%
EBIT growth 3Y-3.85%
EBIT growth 5Y1.02%
EBIT Next Year8.65%
EBIT Next 3Y13.87%
EBIT Next 5YN/A
FCF growth 1Y82.24%
FCF growth 3Y22.27%
FCF growth 5Y13.18%
OCF growth 1Y74.46%
OCF growth 3Y20.41%
OCF growth 5Y11.73%